Don’t miss the latest developments in business and finance.

Granules India receives USFDA approval for generic Aleve PM Tablets

Image
Capital Market
Last Updated : Sep 25 2020 | 12:04 PM IST
Granules India announced today that the US Food & Drug Administration (US FDA) has approved its Abbreviated New Drug Application (ANDA) for Naproxen Sodium and Diphenhydramine Hydrochloride Tablets, 220 mg/25 mg (OTC), generic equivalent of Aleve PM Tablets, 220 mg/25 mg, of Bayer HealthCare LLC.

Naproxen Sodium and Diphenhydramine Hydrochloride Tablets are used for relief of occasional sleeplessness associated with minor aches and pains and to help you fall asleep and stay asleep.

Granules now has a total of 31 ANDA approvals from US FDA (29 Final approvals and 2 tentative approvals).

Aleve PM is a registered trademark of Bayer HealthCare LLC.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: Sep 25 2020 | 11:42 AM IST

Next Story